Study to Explore Early Development – Phase 3

The Study to Explore Early Development (SEED) is a research study funded by the Centers for Disease Control and Prevention (CDC). SEED is currently the largest study in the United States to help identify factors that may put young children at risk for autism spectrum disorder (ASD) and other developmental disabilities. SEED in Missouri is a partnership between the William Greenleaf Elliot Division of Child and Adolescent Psychiatry at Washington University in St. Louis, the Thompson Center for Autism and Neurodevelopmental Disorders at the University of Missouri, and Children’s Mercy Hospital in Kansas City. These institutions will be joining colleagues in Colorado, Georgia, Maryland, North Carolina, and Wisconsin to conduct Phase 3 of the SEED study.

View detailed study information »

Beginning in 2017, investigators will begin inviting families from select Missouri counties to participate in SEED. If you received an invitation in the mail, you may be eligible to participate in SEED. Use the link below, or any of the response options mentioned in your invitation packet, to respond to the invitation.

Respond to SEED Invitation »

If you have any questions about the SEED study, please feel free to contact us.

Lauren Eck, MEd
Study Coordinator

Robert Fitzgerald, PhD, MPH
Co-Principal Investigator